FDA UNTITLED_LETTER - Pavilion Compounding Pharmacy - November 06, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This UNTITLED LETTER record concerns Pavilion Compounding Pharmacy, with an inspection on November 6, 2020, covering drugs.

Company: Pavilion Compounding Pharmacy
Inspection Date: November 6, 2020
Product Type: Drugs
Person: Monica R. Maxwell (Program Division Director)

Open in Dashboard

ID · 092f11a3-fd9c-4e11-a299-b66a20a7130f

Violation Codes10

21 U.S.C. 331(a)21 U.S.C. 331(k)21 CFR 211.18821 U.S.C. 351(a)(2)(A)21 CFR 211.42(c)21 CFR 211.165(a)21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(B)21 CFR 210.1(b)21 CFR 200.10(b)

Full citation text and observation details available on the Dashboard.